Similar articles

• Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.

  Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT. Bellnier DA, et al. Cancer Res. 2003 Nov 15;63(22):7584-90. Cancer Res. 2003. PMID: 14633671
• The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.

  Hsueh W, Sun X, Rioja LN, Gonzalez-Crussi F. Hsueh W, et al. Immunology. 1990 Jul;70(3):309-14. Immunology. 1990. PMID: 2379939 Free PMC article.
• In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.

  Patek PQ, Lin Y. Patek PQ, et al. J Immunol. 1991 May 15;146(10):3457-61. J Immunol. 1991. PMID: 2026874
• Immunomodulation by bacterial endotoxin.

  Burrell R. Burrell R. Crit Rev Microbiol. 1990;17(3):189-208. doi: 10.3109/10408419009105725. Crit Rev Microbiol. 1990. PMID: 1689164 Review. No abstract available.
• TNF in the inflammatory response.

  Männel DN, Echtenacher B. Männel DN, et al. Chem Immunol. 2000;74:141-61. Chem Immunol. 2000. PMID: 10608086 Review. No abstract available.